Sex and gender differences in chronic obstructive pulmonary disease

Research output: Contribution to journalArticle

Abstract

Gender differences are evident in chronic obstructive pulmonary disease (COPD) pathogenesis, manifestations, and response to therapy. Consequently, a better understanding of the gender-influenced factors in COPD pathobiology can help clinicians to make appropriate decisions surrounding the diagnosis and treatment of women with COPD. COPD is underdiagnosed in women, a fact that may reflect discrepancies in presenting symptom profiles in men and women. Women develop COPD at an earlier age with less aggregate tobacco exposure, suggesting enhanced susceptibility to the local toxic effects of cigarette smoke. Gender-by-smoking and gender-by-genetic interactions may underlie many of the sex-disparate features of COPD presentation and clinical course. This article reviews our current understanding of gender as COPD comorbidity and explores possible underlying mechanisms and clinical implications of gender influences in this complex disorder. Recommendations for adjustments in clinical practice and further research are presented.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalClinical Pulmonary Medicine
Volume17
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Sex Characteristics
Chronic Obstructive Pulmonary Disease
Social Adjustment
Poisons
Smoke
Tobacco Products
Tobacco
Comorbidity
Smoking
Therapeutics
Research

Keywords

  • Comorbidity
  • COPD
  • Gender
  • Sex

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Sex and gender differences in chronic obstructive pulmonary disease. / Neptune, Enid.

In: Clinical Pulmonary Medicine, Vol. 17, No. 1, 01.2010, p. 1-6.

Research output: Contribution to journalArticle

@article{1538bf144c4e429b9858562cb297fab4,
title = "Sex and gender differences in chronic obstructive pulmonary disease",
abstract = "Gender differences are evident in chronic obstructive pulmonary disease (COPD) pathogenesis, manifestations, and response to therapy. Consequently, a better understanding of the gender-influenced factors in COPD pathobiology can help clinicians to make appropriate decisions surrounding the diagnosis and treatment of women with COPD. COPD is underdiagnosed in women, a fact that may reflect discrepancies in presenting symptom profiles in men and women. Women develop COPD at an earlier age with less aggregate tobacco exposure, suggesting enhanced susceptibility to the local toxic effects of cigarette smoke. Gender-by-smoking and gender-by-genetic interactions may underlie many of the sex-disparate features of COPD presentation and clinical course. This article reviews our current understanding of gender as COPD comorbidity and explores possible underlying mechanisms and clinical implications of gender influences in this complex disorder. Recommendations for adjustments in clinical practice and further research are presented.",
keywords = "Comorbidity, COPD, Gender, Sex",
author = "Enid Neptune",
year = "2010",
month = "1",
doi = "10.1097/CPM.0b013e3181c79436",
language = "English (US)",
volume = "17",
pages = "1--6",
journal = "Clinical Pulmonary Medicine",
issn = "1068-0640",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Sex and gender differences in chronic obstructive pulmonary disease

AU - Neptune, Enid

PY - 2010/1

Y1 - 2010/1

N2 - Gender differences are evident in chronic obstructive pulmonary disease (COPD) pathogenesis, manifestations, and response to therapy. Consequently, a better understanding of the gender-influenced factors in COPD pathobiology can help clinicians to make appropriate decisions surrounding the diagnosis and treatment of women with COPD. COPD is underdiagnosed in women, a fact that may reflect discrepancies in presenting symptom profiles in men and women. Women develop COPD at an earlier age with less aggregate tobacco exposure, suggesting enhanced susceptibility to the local toxic effects of cigarette smoke. Gender-by-smoking and gender-by-genetic interactions may underlie many of the sex-disparate features of COPD presentation and clinical course. This article reviews our current understanding of gender as COPD comorbidity and explores possible underlying mechanisms and clinical implications of gender influences in this complex disorder. Recommendations for adjustments in clinical practice and further research are presented.

AB - Gender differences are evident in chronic obstructive pulmonary disease (COPD) pathogenesis, manifestations, and response to therapy. Consequently, a better understanding of the gender-influenced factors in COPD pathobiology can help clinicians to make appropriate decisions surrounding the diagnosis and treatment of women with COPD. COPD is underdiagnosed in women, a fact that may reflect discrepancies in presenting symptom profiles in men and women. Women develop COPD at an earlier age with less aggregate tobacco exposure, suggesting enhanced susceptibility to the local toxic effects of cigarette smoke. Gender-by-smoking and gender-by-genetic interactions may underlie many of the sex-disparate features of COPD presentation and clinical course. This article reviews our current understanding of gender as COPD comorbidity and explores possible underlying mechanisms and clinical implications of gender influences in this complex disorder. Recommendations for adjustments in clinical practice and further research are presented.

KW - Comorbidity

KW - COPD

KW - Gender

KW - Sex

UR - http://www.scopus.com/inward/record.url?scp=75749089723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749089723&partnerID=8YFLogxK

U2 - 10.1097/CPM.0b013e3181c79436

DO - 10.1097/CPM.0b013e3181c79436

M3 - Article

AN - SCOPUS:75749089723

VL - 17

SP - 1

EP - 6

JO - Clinical Pulmonary Medicine

JF - Clinical Pulmonary Medicine

SN - 1068-0640

IS - 1

ER -